Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;10(21):e2100957.
doi: 10.1002/adhm.202100957. Epub 2021 Sep 26.

Short-Term Preclinical Application of Functional Human Induced Pluripotent Stem Cell-Derived Airway Epithelial Patches

Affiliations

Short-Term Preclinical Application of Functional Human Induced Pluripotent Stem Cell-Derived Airway Epithelial Patches

Ratna Varma et al. Adv Healthc Mater. 2021 Nov.

Abstract

Airway pathologies including cancer, trauma, and stenosis lack effective treatments, meanwhile airway transplantation and available tissue engineering approaches fail due to epithelial dysfunction. Autologous progenitors do not meet the clinical need for regeneration due to their insufficient expansion and differentiation, for which human induced pluripotent stem cells (hiPSCs) are promising alternatives. Airway epithelial patches are engineered by differentiating hiPSC-derived airway progenitors into physiological proportions of ciliated (73.9 ± 5.5%) and goblet (2.1 ± 1.4%) cells on a silk fibroin-collagen vitrigel membrane (SF-CVM) composite biomaterial for transplantation in porcine tracheal defects ex vivo and in vivo. Evaluation of ex vivo tracheal repair using hiPSC-derived SF-CVM patches demonstrate native-like tracheal epithelial metabolism and maintenance of mucociliary epithelium to day 3. In vivo studies demonstrate SF-CVM integration and maintenance of airway patency, showing 80.8 ± 3.6% graft coverage with an hiPSC-derived pseudostratified epithelium and 70.7 ± 2.3% coverage with viable cells, 3 days postoperatively. The utility of bioengineered, hiPSC-derived epithelial patches for airway repair is demonstrated in a short-term preclinical survival model, providing a significant leap for airway reconstruction approaches.

Keywords: airway defects; biomaterials; bioreactors; in vivo; induced pluripotent stem cells; survival models; tissue engineering; trachea.

PubMed Disclaimer

Similar articles

Cited by

References

    1. H. C. Grillo, Ann. Thorac. Surg. 2002, 73, 1995.
    1. P. R. Delaere, J. J. Vranckx, J. Meulemans, V. Vander Poorten, K. Segers, D. Van Raemdonck, P. De Leyn, H. Decaluwe, C. Dooms, G. Verleden, Am. J. Transplant. 2012, 12, 2538.
    1. P. Delaere, D. Van Raemdonck, J. Vranckx, Intensive Care Med. 2019, 45, 391.
    1. J. M. Fishman, M. Lowdell, M. A. Birchall, Semin. Pediatr. Surg. 2014, 23, 119.
    1. a) J. M. Gauthier, D. Ruiz-Perez, W. J. Li, R. R. Hachem, V. Puri, A. E. Gelman, D. Kreisel, Transplantation 2018, 102, 1459;

Publication types

LinkOut - more resources